Acura Pharmaceuticals Shares Down 21.7% Since SmarTrend Said Sell (ACUR)

SmarTrend identified a Downtrend for Acura Pharmaceuticals ACUR on June 23, 2011 at $3.81. In approximately 1 month, Acura Pharmaceuticals has returned 21.7% as of today's recent price of $2.98.

In the past 52 weeks, shares of Acura Pharmaceuticals have traded between a low of $2.20 and a high of $6.80 and are now at $2.98, which is 35% above that low price.

Acura Pharmaceuticals is currently below its 50-day moving average of $3.88 and below its 200-day moving average of $3.50. Look for these moving averages to decline to confirm the company's downward momentum.

In the last five trading sessions, the 50-day MA has fallen 2.93% while the 200-day MA has risen 0.25%.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Acura Pharmaceuticals.

Write to Chip Brian at cbrian@mysmartrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.mysmartrend.com/signup